Interbody Fusion Cage Market Overview:

Interbody Fusion Cage is an implantable medical device used to maintain the forminal height of the spine. Interbody fusion cages are inserted between the spinal cords when the space between the discs is distracted. These interbody fusion cages are made from materials such as titanium, carbon fiber, or allograft femur. The global interbody fusion cage market was valued at $1,818 million in 2016, and is expected to reach $2,309 million by 2023 at a CAGR of 3.4% during the forecast period.

Rise in geriatric population and increase in incidences of spinal injuries and sports injuries drive the growth of the market. In addition, surge in demand for interbody fusion cage surgeries due to advantages that allow the surgeon to directly decompress nerves and reconstruct the spine further fuels the market growth. However, high costs associated with spinal fusion surgeries, lack of trained professionals as well as stringent rules & regulations to use these devices hamper the market growth. Moreover, the launch of novel interbody fusion cages with new compatible materials create more opportunities in the market.

The global interbody fusion cage market is segmented based on product, surgery type, end user, and region. Based on product, it is divided into lumbar, cervical, thoraco-lumbar, and thoracic. Based on surgery, it is classified into anterior, posterior, lateral, and transforaminal. Based on end user, it is divided into hospital, clinic, medical center, and other end users. Based on region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Based on product, thoraco-lumbar segment is expected to be the most lucrative segment, as the thoraco-lumbar spine is the most affected area by diseases and injuries such as disc degenerative disease, trauma, tumor, and infectious diseases, which are mainly treated by spinal interbody fusion cage technique. Thus, driving the growth of the interbody fusion cage market.

Based on surgery type, the anterior surgery segment dominated the market in 2016, owing to the easy and convenient implantation of larger bone cages and grafts, facilitating improved initial stability and compression of the fusion construct.

Based on region, North America dominated the global market in 2016, and is expected to retain its dominance throughout the forecast period. This is attributed to the well-established healthcare infrastructure and increase in adoption of interbody fusion cage across various healthcare settings.

Request for Table of Content

The utilization of interbody fusion cage is projected to witness an increase in the coming years, owing to the rapid rise in geriatric population and the increase in incidence of spinal injuries. This market is largely segregated, and several manufacturers focus on offering advanced products that provide enhanced support, durability, and biocompatibility. Technological innovation such as development of more biocompatible cages made of PEEK is adopted as a principal strategy to increase the bargaining power of the buyers.

Novel interbody fusion cages have emerged as promising medical devices that provide mechanical support to the spine and offer stabilization as well. Moreover, the launch of innovative interbody fusion cages and the rise in demand of minimally invasive surgeries further help supplement the market growth. However, the cost associated with spinal fusion devices and surgeries are higher thus impeding the growth of the interbody fusion cage market. However, increased adoption of minimally invasive surgeries further create lucrative opportunities in the market.

The adoption of interbody fusion cage is highest in North America and Europe, due to high affordability and increased awareness about the benefits associated with interbody fusion cages. Moreover, Asia-Pacific is anticipated to grow at a fast pace owing to its high population base. The significant increase in spinal injuries also fuels the growth. In addition, upsurge in medical tourism, growth in disposable incomes, and rise in awareness among patients toward advanced interbody fusion devices boost the market growth in this region. Moreover, the medical device companies such as Titan Spine, Inc. and K2M have launched several interbody fusion devices and thus expanded their presence in Asia-Pacific, which in turn boosts the growth of the interbody fusion cage market.